Effects of leukotriene D on the airways in asthma.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  New England Journal of Medicine

• Publication date

  1983-02-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198302243080807PMID 6823253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bronchoconstrictor effects of leukotriene C in humans.

  1982cited by this paper
• Bronchoconstriction produced in man by leukotrienes C and D.

  1981cited by this paper
• Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro

  1981cited by this paper
• Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

  1980cited by this paper
• Bronchial hyperreactivity.

  1980cited by this paper
• Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187.

  1980cited by this paper
• Leukotriene C: a slow-reacting substance from murine mastocytoma cells.

  1979cited by this paper
• Reproducibility and comparison of responses to inhaled histamine and methacholine.

  1978cited by this paper
• Comparative action of acetyl-beta-methylcholine, histamine, and pollen antigens in subjects with hay fever and patients with bronchial asthma

  1965cited by this paper
• METHACHOLINE AEROSOL AS TEST FOR BRONCHIAL ASTHMA.

  1965cited by this paper
• Slow reacting substance and related compounds.

  1962cited by this paper

• Leukotriene receptors in GtoPdb v.2025.3

  2025cites this paper
• Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation

  2025cites this paper
• Are leukotrienes really the world's best bronchoconstrictors and at least 100 to 1000 times more potent than histamine?

  2025cites this paper
• Leukotriene receptors in GtoPdb v.2023.1 Leukotriene receptors in GtoPdb v.2023.1

  2023cites this paper
• Modified enhanced recovery after surgery protocol in patients with acute cholecystitis: efficacy, safety and feasibility. Multicenter randomized control study

  2021cites this paper
• Management Strategies to Reduce Exacerbations in non-T2 Asthma.

  2021cites this paper
• Exploring the origin and regulatory role of mast cells in asthma

  2020cites this paper
• HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells

  2020cites this paper
• Leukotriene D4 Paradoxically Limits LTC4 Driven Platelet Activation and Lung Immunopathology.

  2020cites this paper
• Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions.

  2019cites this paper
• Mast Cells and Their Progenitors in Allergic Asthma

  2019cites this paper
• Function of secreted phospholipase A2 group-X in asthma and allergic disease.

  2019cites this paper
• Bronchoprovocation studies to define mechanisms in asthma and airway inflammation

  2019cites this paper
• Giants in Chest Medicine: Jeffrey M. Drazen, MD, FCCP.

  2018cites this paper
• Giants in Chest Medicine: Steven E. Weinberger, MD, FCCP.

  2017cites this paper
• The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field

  2017cites this paper
• The measurement of cough response to bronchoconstriction induced by methacholine inhalation in healthy subjects: An examination using the Astograph method

  2017cites this paper
• clinical implications 01basic research Inhalation Challenge with Sultidopeptide Leukotrienes in Human Subjects

  2017cites this paper
• Leukotriene Receptor Antagonists and Antiallergy Drugs.

  2017cites this paper
• Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets

  2016cites this paper
• Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils.

  2016cites this paper
• Bronchial challenge tests with direct and indirect stimuli – Which are more useful?

  2015cites this paper
• Cysteinyl leukotrienes: an innate system for epithelial control of airway smooth muscle proliferation?

  2015cites this paper
• Cysteinyl Leukotrienes: An Innate System for Epithelial Control of Airway Smooth Muscle Proliferation?

  2015cites this paper
• The promise and peril of functional genomics in chronic obstructive pulmonary disease.

  2015cites this paper
• Cysteinyl Leukotrienes and Disease

  2015cites this paper
• Differentiated into Eosinophils Receptor Expression in HL-60 Cells IL-5 Up-Regulates Cysteinyl Leukotriene 1

  2013cites this paper
• Mechanisms of allergic diseases

  2013cites this paper
• Chapter 6 – Airway Pharmacology

  2013cites this paper
• Exercise-induced bronchoconstriction.

  2013cites this paper
• Cysteinyl leukotriene receptors, old and new; implications for asthma

  2012cites this paper
• COX inhibitors for airway inflammation

  2012cites this paper
• Zafirlukast

  2012cites this paper
• Leukotrienes as a Target in Asthma Therapy

  2012cites this paper
• The Role of Arachidonic Acid Metabolites in Local and Systemic Inflammatory Processes

  2012cites this paper
• Zafirlukast

  2012cites this paper
• Clinical Evidence with Montelukast in the Management of Chronic Childhood Asthma

  2012cites this paper
• Diet and asthma

  2010cites this paper
• Leukotriene E4: perspective on the forgotten mediator.

  2009cites this paper
• Evaluation of Cysteinyl Leukotriene-Induced Contraction of Human Cultured Bronchial Smooth Muscle Cells

  2009cites this paper
• Chapter 24 – Leukotrienes and Lipoxins

  2009cites this paper
• The role of leukotrienes in airway remodeling.

  2009cites this paper
• Antileukotrienes in Asthma and Rhinitis

  2009cites this paper
• Therapeutic immunomodulation of allergic lung disease using regulatory dendritic cells in a mouse model of asthma

  2009cites this paper
• The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.

  2009cites this paper
• Mammalian Host Defenses: Innate and Adaptive Immunity

  2009cites this paper
• Doing what I like.

  2008cites this paper
• Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness.

  2007cites this paper
• The pharmacology of airway hyperresponsiveness and inflammation

  2007cites this paper
• Cysteinyl leukotriene D4 increases human detrusor muscle responsiveness to histamine.

  2006cites this paper
• Differences in the Evaluation and Management of Exercise-Induced Bronchospasm between Family Physicians and Pulmonologists

  2006cites this paper
• Variable therapeutic response in asthma: a genetic perspective.

  2006cites this paper
• Treatment of asthma with antileukotrienes: first line or last resort therapy?

  2006cites this paper
• Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism.

  2006cites this paper
• Association Between A Leukotriene C4 Synthase Gene Promoter Polymorphism and Coronary Artery Calcium in Young Women: The Muscatine Study

  2006cites this paper
• Role of human mast cells and basophils in bronchial asthma.

  2005cites this paper
• Exercise-induced bronchoconstriction in athletes.

  2005cites this paper
• ALOX5 promoter genotype, asthma severity and LTC4 production by eosinophils

  2005cites this paper
• Medical Flogress Prostag land ins, Throm boxanes and Leu kotrienes in Clinical Medicine

  2005cites this paper
• Expression of functional cysteinyl leukotriene receptors by human basophils.

  2005cites this paper
• The cysteinyl-leukotriene-1 receptor antagonist zafirlukast is a potent secretagogue in rat and human airways.

  2005cites this paper
• Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis

  2005cites this paper
• Only cell and molecular biology can lead to an understanding of pathogenesis of lung disease.

  2004cites this paper
• Leukotrienes and isocyanate‐induced asthma: a pilot study

  2004cites this paper
• Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.

  2004cites this paper
• Leukotriene receptor antagonists – risks and benefits for use in paediatric asthma

  2004cites this paper
• Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.

  2004cites this paper
• Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study

  2004cites this paper
• Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.

  2004cites this paper
• Absence of deep inspiration-induced bronchoprotection against inhaled allergen.

  2003cites this paper
• Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R

  2003cites this paper
• Leukotriene receptor antagonists in asthma therapy.

  2003cites this paper
• Cysteinyl-leukotrienes and the liver.

  2003cites this paper
• International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors

  2003cites this paper
• Mast cells: beyond IgE.

  2003cites this paper
• The role of mast cells in asthma.

  2003cites this paper
• The organization and consequences of eicosanoid signaling.

  2003cites this paper
• Exercise-Induced Bronchospasm in the Elite Athlete

  2002cites this paper
• Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor.

  2002cites this paper
• Leukotriene Receptor Antagonists

  2002cites this paper
• Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.

  2001cites this paper
• T Helper Cell Type 2 Cytokines Coordinately Regulate Immunoglobulin E–Dependent Cysteinyl Leukotriene Production by Human Cord Blood–Derived Mast Cells

  2001cites this paper
• Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma.

  2001cites this paper
• Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

  2001cites this paper
• Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells

  2001cites this paper
• Attenuated Zymosan-induced Peritoneal Vascular Permeability and IgE-dependent Passive Cutaneous Anaphylaxis in Mice Lacking Leukotriene C4 Synthase*

  2001cites this paper
• Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics.

  2001cites this paper
• Current treatment of asthma--focus on leukotrienes.

  2000cites this paper
• Mast cells and basophils

  2000cites this paper
• Role of antileukotriene agents in asthma therapy

  2000cites this paper
• IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils1

  2000cites this paper
• PATHOLOGY OF ASTHMA

  2000cites this paper
• Leukotriene receptor antagonists: Efficacy and safety in children with asthma

  2000cites this paper
• Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo.

  2000cites this paper
• Current treatment of asthma - focus on leukotrienes

  2000cites this paper
• Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma

  2000cites this paper
• Asthma. From bronchoconstriction to airways inflammation and remodeling.

  2000cites this paper
• Leukotriene Receptor Antagonists and 5-Lipoxygenase Inhibitors in Asthma

  2000cites this paper